Where Can I Buy NAD+ 500mg?
September 9, 2026
Researchers looking for NAD+ 500mg for laboratory research can purchase it from Neuro Peptides. NAD+,
Researchers looking for Retatrutide 10mg for laboratory research can find this research compound at NeuroPeptides. Retatrutide, also known as LY3437943, is an investigational peptide that activates the following three receptors:
NeuroPeptides currently lists Retatrutide in several vial sizes, including a 10mg research vial.
According to NeuroPeptides, its research peptides undergo independent third-party testing using HPLC and mass spectrometry. The company also provides batch-specific COA documentation for its products.
For researchers evaluating Retatrutide 10mg, the main factors to review include:
Retatrutide remains an investigational compound and is not FDA-approved. Eli Lilly continues to develop it through clinical trials, so research material should not be presented as an approved medication or as equivalent to clinical-trial material.
For this reason, researchers should evaluate both the supplier documentation and the intended research application before purchasing Retatrutide 10mg.
Yes. NeuroPeptides states that its Retatrutide batches undergo independent third-party testing for research-quality verification. The company identifies HPLC and mass spectrometry as its primary analytical methods for peptide testing.
For researchers evaluating Retatrutide 10mg, these methods provide different types of analytical information:
NeuroPeptides also states that it supplies its products with batch-specific third-party COAs. Researchers can use these documents to review the reported testing results before adding the material to a laboratory research workflow.
Importantly, third-party testing should not be treated as proof of clinical safety or therapeutic effectiveness. Retatrutide remains an investigational compound and is not FDA-approved for human use.
For a research purchase, the most useful approach is to review the COA, batch number, analytical methods, and reported results together.
Yes. NeuroPeptide states that every batch comes with a third-party Certificate of Analysis (COA) that reports identity and purity results based on independent HPLC and mass spectrometry testing. The company also says its products are sold strictly for laboratory and in-vitro research.
For researchers considering Retatrutide 10mg, the COA is one of the most useful documents to review before placing an order. A batch-specific COA can help connect the product received with the analytical results reported for that lot.
A useful Retatrutide COA should ideally show:
NeuroPeptide specifically states that its Retatrutide and other research peptides undergo independent third-party testing using HPLC and mass spectrometry.
Yes. NeuroPeptide’s current contact page states that researchers can request a COA before purchase by submitting the product name or lot information through its research desk. The company says it can provide the most recent certificate for the requested material.
This provides an important advantage for researchers who want to review documentation before making a purchasing decision. Instead of relying only on a product-page purity claim, researchers can request the actual analytical documentation associated with the material.
It is still important to read the COA carefully. A third-party label alone does not establish every aspect of peptide quality. HPLC and mass spectrometry address specific analytical questions, while attributes such as sterility, endotoxin levels, residual solvents, and stability may require separate testing.
For Retatrutide research, a batch-specific COA provides a much stronger quality signal than a generic “high purity” statement. Researchers should compare the lot number on the COA with the material they receive and retain the document as part of their laboratory records.
Neuropeptides currently lists Retatrutide 10mg at $80 per vial. The product page also shows several other vial sizes, giving researchers multiple quantity options.
| Retatrutide Size | Listed Price |
| 5mg | $54 |
| 10mg | $80 |
| 15mg | $119 |
| 20mg | $145 |
| 30mg | $300 |
The product page describes the 10mg vial as formulated for controlled laboratory research and states that it is independently tested. The page also identifies the material as research use only and not for human consumption.
For researchers specifically looking for Retatrutide 10mg, the current listed price is therefore $80 per vial. Researchers should still check the product page before ordering because supplier pricing can change over time.
The price should also be considered alongside the available COA, analytical testing, batch information, storage documentation, and research-use labeling. Neuro Peptides states that its research peptides undergo third-party testing and that its testing process includes HPLC and mass spectrometry.
NeuroPeptides does not currently publish a fixed shipping fee for Retatrutide 10mg on its public product or FAQ pages. Shipping costs may depend on the order and delivery destination.
Researchers should therefore check the checkout page for the current shipping charge before completing an order. For questions about delivery costs, Neuro Peptides also provides a contact form for research and product inquiries.
The company currently states that it ships research peptide orders to laboratories across the United States. International orders are handled case by case for verified research institutions.
Because shipping rates can change based on destination and order details, the most accurate approach is to confirm the delivery charge at checkout or contact NeuroPeptides before purchasing Retatrutide 10mg.
Shipping time depends on the supplier’s processing schedule, destination, and selected delivery method.
NeuroPeptides currently presents its ordering process around a five-day timeline from browsing the catalog to laboratory delivery. However, actual delivery times can vary because carriers, weekends, holidays, and international customs can affect transit.
Researchers who need retatrutide for a scheduled laboratory project should confirm the expected processing and delivery window before placing an order.
A Certificate of Analysis is one of the most useful documents researchers can review when evaluating a research peptide supplier.
NeuroPeptides states that its batches come with third-party COAs. The company also says these reports include purity testing through HPLC and mass spectrometry.
Before purchasing, researchers should review the COA for several key details:
A COA should identify the specific batch supplied to the customer. A generic laboratory report provides less useful verification.
No. Retatrutide is not FDA-approved as of August 31, 2026.
Eli Lilly continues to describe retatrutide as an investigational medication under clinical development. The company reported multiple Phase 3 results during 2026, but FDA approval has not yet occurred.
The FDA also states that retatrutide is not a component of an FDA-approved drug and cannot be used for compounding under federal law.
This distinction matters for anyone searching for retatrutide 10mg for research. A research peptide sold by a supplier is not the same thing as an FDA-approved pharmaceutical product.
Retatrutide 10mg is used for laboratory research into the impact on GIP, GLP-1, and glucagon receptors. This includes examining potential effects on metabolic and endocrine function.
Yes, LY3437943 is the code name for retatrutide. The terms refer to the same investigational compound.
Check the COA, batch number, purity information, identity testing, storage instructions, and supplier information. Batch-specific information about your product will help provide product traceability.
Check the HPLC report and other analytical information from the supplier. You may also wish to send the material for mass spectrometry to confirm the molecular identity.
This depends on the supplier. Check that the Certificate of Analysis (COA) relates to the batch number shown on the product that you receive.
Follow the storage instructions provided by the supplier. Storage conditions may differ between products and companies.
Research grade Retatrutide is sold for research into the effects of the active substance, while clinical trial material is manufactured under controlled pharmaceutical conditions. The materials should not be regarded as interchangeable.
Some companies sell Retatrutide for research purposes. Researchers should check the terms of supply and information provided by the supplier.
No, Retatrutide is not an FDA-approved substance as of August 2026. The substance is currently under clinical development.
The COA provides information about a specific batch of material, including purity information, identity testing, analytical methods, and laboratory information. This lets researchers read through documentation about a specific batch before buying a product.
Retatrutide happens to be one of the most intensely studied of the triple receptor agonists. Its GIP, GLP-1, and glucagon receptor activity have yielded interesting results, and Phase 3 development is set to produce more data in 2026.
The considerations for the research peptide Retatrutide 10 mg are not limited to price. Product type, COA, HPLC purity, mass spec, third-party test reports, shipping conditions, and research-use labeling should also be taken into account.
Most importantly, the drug is not FDA-approved as of August 2026, and any commercial research-peptide product should be kept separate from FDA-approved pharmaceuticals and products.
Research Use Only: Peptide products offered by NeuroPeptides are for research purposes only and are not intended for human consumption, diagnosis, treatment, or prevention of disease.
Researchers looking for NAD+ 500mg for laboratory research can purchase it from Neuro Peptides. NAD+,
Mitochondria have long been understood as essential sites of cell energy production; however, accumulating evidence
Researchers looking for Retatrutide 10mg for laboratory research can find this research compound at NeuroPeptides.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide (MDP) that has attracted growing interest in research on
MOTS-C is a mitochondrial-derived peptide (MDP) that has been extensively investigated in the context of
MOTS-C is one of the latest mitochondrial-derived research peptides being investigated with growing interest in